Philogen SpA (FRA:78Q) FFO


FRA:78Q Philogen SpA FRA:78Q
69 GF Score
Price €22.05
GF Value €215.49
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Philogen SpA FFO?

FFO (Funds from operations) only applies to REITs.

FRA:78Q
69GF Score
Philogen SpA FRA:78Q
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Philogen SpA (FRA:78Q) Overvalued in 2026?

Based on GuruFocus' analysis, Philogen SpA stock appears to be undervalued. The current stock price of €22.05 is trading 89.8% below its estimated GF Value™ of €215.49. GuruFocus considers Philogen SpA to be Possible Value Trap.

Key valuation signals for FRA:78Q:

  • FFO:
  • GF Value™: €215.49 vs. price of €22.05 (89.8% below fair value)
  • GF Score™: 69/100 with 3 warning signs

No single metric tells the full story. See the FRA:78Q stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Philogen SpA Business Description

Other Exchanges PHIL:Italy
Address Piazza La Lizza No. 7, Siena, ITA, 53100
Philogen SpA is a biotechnology company engaged in the research and development of antibody-based therapeutics for the treatment of cancer and chronic inflammatory diseases. The company's pipeline includes products such as Nidlegy, Fibromun, Darleukin, and Dekavil, targeting oncology and other serious conditions. Geographically, the company operates in the European Union, Switzerland, and the United States of America.
69GF Score

Get the complete analysis for FRA:78Q

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€22.05
Price
€215.49
GF Value